New treatment could be instrumental in restoring the blood-brain barrier’s normal function

FHS
June 20, 2023
4:51 pm

There’s a bouncer in everyone: The blood-brain barrier, a layer of cells between blood vessels and the rest of the brain, kicks out toxins, pathogens and other undesirables that can sabotage the brain’s precious gray matter.

UCB wins FDA approvals in plaque psoriasis and gMG, unlocking blockbuster opportunities

UCB’s treatment candidates for plaque psoriasis and generalized myasthenia gravis have both bagged approvals in the US, expanding current market opportunities and opening up new

October 19, 2023

Using advanced CRISPR to boost efficiency of CAR-T cell therapies

CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first approved in 2017 in the

August 2, 2024

Brain cell connections weakened during first half of sleep, study reveals

During sleep, the brain weakens the new connections between neurons that had been forged while awake – but only during the first half of a

May 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.